Search

everythinglearnresearchcommunity

for

Search:↓

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Finasteride treats baldness but may cause lasting sexual side effects.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Dutasteride and finasteride don't raise erectile dysfunction risk.

No clear link found between finasteride and suicidal thoughts or actions.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Finasteride helped treat a 28-year-old's facial skin condition.

Finasteride's two forms have different stability based on temperature and pressure.

Eosinophilic cystitis is often misdiagnosed, but accurate diagnosis and treatment improve outcomes.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

Finasteride safely lowers DHT levels without affecting testosterone.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Sabal and Urtica extract works as well as finasteride for treating BPH, with fewer side effects.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

New dissolving and implantable microneedle patches have been created for a long-lasting, non-invasive delivery of the drug finasteride.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Finasteride use during early pregnancy may cause limb deformities in babies.

Finasteride use may be linked to rare testicular tumor, but more research needed.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

A new compound was made that might help treat diseases related to male hormones.

Finasteride effectively treats BPH but requires continuous use to maintain benefits.

Endurance exercise may help BPH by lowering hormones and inflammation.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.